188 related articles for article (PubMed ID: 16192741)
1. Production of salivary immunoglobulin A and suppression of Dermatophagoides pteronyssinus-induced airway inflammation by local nasal immunotherapy.
Liu YH; Tsai JJ
Int Arch Allergy Immunol; 2005 Oct; 138(2):161-8. PubMed ID: 16192741
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of local nasal immunotherapy for Dp2-induced airway inflammation in mice: Using Dp2 peptide and fungal immunomodulatory peptide.
Liu YH; Kao MC; Lai YL; Tsai JJ
J Allergy Clin Immunol; 2003 Aug; 112(2):301-10. PubMed ID: 12897735
[TBL] [Abstract][Full Text] [Related]
3. DNA vaccine encoding Der p 2 allergen generates immunologic protection in recombinant Der p 2 allergen-induced allergic airway inflammation mice model.
Li GP; Liu ZG; Qiu J; Ran PX; Zhong NS
Chin Med J (Engl); 2005 Apr; 118(7):534-40. PubMed ID: 15820083
[TBL] [Abstract][Full Text] [Related]
4. Effects of local nasal immunotherapy in allergic airway inflammation: Using urea denatured Dermatophagoides pteronyssinus.
Yu SJ; Liao EC; Tsai JJ
Hum Vaccin Immunother; 2015; 11(4):915-21. PubMed ID: 25933184
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of DNA vaccine on allergen-induced allergic airway inflammation in mouse model.
Li G; Liu Z; Zhong N; Liao B; Xiong Y
Cell Mol Immunol; 2006 Oct; 3(5):379-84. PubMed ID: 17092436
[TBL] [Abstract][Full Text] [Related]
6. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus.
Tsai JJ; Liao EC; Tsai FH; Hsieh CC; Lee MF
J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124
[TBL] [Abstract][Full Text] [Related]
7. Clinical effectiveness of Tyrophagus putrescentiae allergy by local nasal immunotherapy using strips of Dermatophagoides pteronyssinus.
Liao EC; Tsai JJ
J Asthma; 2011 Nov; 48(9):957-64. PubMed ID: 21895564
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Dp2 nasal therapy for Dp2- induced airway inflammation in mice: using oral Ganoderma lucidum as an immunomodulator.
Liu YH; Tsai CF; Kao MC; Lai YL; Tsai JJ
J Microbiol Immunol Infect; 2003 Dec; 36(4):236-42. PubMed ID: 14723251
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of allergen-induced airway inflammation by low-dose oral immunotherapy with transgenic rice seeds independently of immunoglobulin e synthesis.
Saeki M; Nishimura T; Kaminuma O; Suzuki K; Takai T; Mori A; Takada K; Takaiwa F; Hiroi T
Int Arch Allergy Immunol; 2012; 158 Suppl 1():66-9. PubMed ID: 22627369
[TBL] [Abstract][Full Text] [Related]
10. Local nasal immunotherapy: efficacy of Dermatophagoides farinae-chitosan vaccine in murine asthma.
Liu Z; Guo H; Wu Y; Yu H; Yang H; Li J
Int Arch Allergy Immunol; 2009; 150(3):221-8. PubMed ID: 19494519
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro immunomodulation of Der p 1 allergen-specific response by Lactobacillus plantarum bacteria.
Hisbergues M; Magi M; Rigaux P; Steuve J; Garcia L; Goudercourt D; Pot B; Pestel J; Jacquet A
Clin Exp Allergy; 2007 Sep; 37(9):1286-95. PubMed ID: 17845408
[TBL] [Abstract][Full Text] [Related]
12. Expression and characterization of natural-like recombinant Der p 2 for sublingual immunotherapy.
Bordas-Le Floch V; Bussières L; Airouche S; Lautrette A; Bouley J; Berjont N; Horiot S; Huet A; Jain K; Lemoine P; Chabre H; Batard T; Mascarell L; Baron-Bodo V; Tourdot S; Nony E; Moingeon P
Int Arch Allergy Immunol; 2012; 158(2):157-67. PubMed ID: 22286395
[TBL] [Abstract][Full Text] [Related]
13. Oral administration of a mite allergen expressed by zucchini yellow mosaic virus in cucurbit species downregulates allergen-induced airway inflammation and IgE synthesis.
Hsu CH; Lin SS; Liu FL; Su WC; Yeh SD
J Allergy Clin Immunol; 2004 Jun; 113(6):1079-85. PubMed ID: 15208588
[TBL] [Abstract][Full Text] [Related]
14. Effects of Local Nasal Immunotherapy with FIP-fve Peptide and Denatured Tyrophagus putrescentiae for Storage Mite-Induced Airway Inflammation.
Yen CY; Yu CH; Tsai JJ; Tseng HK; Liao EC
Arch Immunol Ther Exp (Warsz); 2022 Jan; 70(1):6. PubMed ID: 35099617
[TBL] [Abstract][Full Text] [Related]
15. Sublingual immunotherapy efficacy of Dermatophagoides farinae vaccine in a murine asthma model.
Yu HQ; Li XH; Guo H; Liu ZG; Ran PX; Ji KM; Wang J
Int Arch Allergy Immunol; 2010; 152(1):41-8. PubMed ID: 19940504
[TBL] [Abstract][Full Text] [Related]
16. Comparison of purified Dermatophagoides pteronyssinus allergens and extract by two-dimensional immunoblotting and quantitative immunoglobulin E inhibitions.
Weghofer M; Thomas WR; Pittner G; Horak F; Valenta R; Vrtala S
Clin Exp Allergy; 2005 Oct; 35(10):1384-91. PubMed ID: 16238800
[TBL] [Abstract][Full Text] [Related]
17. Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering.
Chen KW; Fuchs G; Sonneck K; Gieras A; Swoboda I; Douladiris N; Linhart B; Jankovic M; Pavkov T; Keller W; Papadopoulos NG; Valent P; Valenta R; Vrtala S
Mol Immunol; 2008 May; 45(9):2486-98. PubMed ID: 18295887
[TBL] [Abstract][Full Text] [Related]
18. Immune reactivity of recombinant group 2 allergens of house dust mite, Dermatophagoides pteronyssinus, and Dermatophagoides farinae.
Jin HS; Yong TS; Park JW; Hong CS; Oh SH
J Investig Allergol Clin Immunol; 2003; 13(1):36-42. PubMed ID: 12861849
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of allergen-induced airway inflammation and hyperreactivity by recombinant lactic-acid bacteria.
Charng YC; Lin CC; Hsu CH
Vaccine; 2006 Aug; 24(33-34):5931-6. PubMed ID: 16814902
[TBL] [Abstract][Full Text] [Related]
20. Development of recombinant stable house dust mite allergen Der p 3 molecules for component-resolved diagnosis and specific immunotherapy.
Bouaziz A; Walgraffe D; Bouillot C; Herman J; Foguenne J; Gothot A; Louis R; Hentges F; Jacquet A; Mailleux AC; Chevigné A; Galleni M; Adam E; Dumez ME
Clin Exp Allergy; 2015 Apr; 45(4):823-34. PubMed ID: 25406386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
